Archive · 8 Nov 2025
Serotonin, the 'Happiness Chemical,' May Fuel Cancer Growth
Imagine serotonin as a messenger in your body.
We usually think of it as the 'happy messenger' that helps you feel good.
But scientists have found that serotonin, especially the kind made in your tummy, can also act like a messenger for cancer.
This tummy serotonin can go into cells and tell certain genes to start growing, which can help tumors get bigger.
This is different from how serotonin works in your brain to control your mood.
Researchers are now trying to figure out how to stop this cancer-helping messenger without affecting the happy messenger.
They are looking at special medicines that can block these messengers from getting into cancer cells or therapies that can turn off the bad genes.
This could lead to new ways to fight cancer.
Serotonin, known for regulating mood, is also being investigated for its potential role in fueling cancer growth.
Nearly 95% of the body's serotonin is produced in the gut and travels to various tissues, not just the brain.
Research from 2019 revealed that serotonin can enter cells and interact with DNA, activating genes.
Studies indicate this mechanism can switch on genes associated with tumor development in various cancers.
Scientists are exploring targeted therapies, including managing serotonin levels and using SSRIs, to combat serotonin-driven cancer growth.
- Who
- Scientists at the University of Limerick and Icahn School of Medicine at Mount Sinai
- What
- New research suggests serotonin, primarily produced in the gut, may fuel cancer growth by interacting with DNA and switching on genes linked to tumor development.
- When
- Research published in 2019 and ongoing studies.
- Where
- Research conducted in Ireland and New York; findings applicable to brain, liver, and pancreatic cancers, with potential implications for others.
- Why
- To understand the dual role of serotonin in mood regulation and its potential involvement in cancer development, aiming to develop new therapeutic strategies.
SSRIs as a Potential Cancer Treatment
Concerns about SSRIs and Cancer
Impact of SSRIs on Cancer
SSRIs as a Potential Cancer Treatment
SSRIs may have beneficial effects against certain cancers by blocking serotonin's entry into cancer cells, potentially complementing existing therapies.
Concerns about SSRIs and Cancer
While SSRIs increase serotonin levels in the brain to treat depression, people taking these medications do not need to worry about them driving cancer growth, as brain and gut serotonin operate independently.
- Serotonin Production
- Almost 95% of the body's serotonin is produced in the gut.
- Gut Serotonin Functions
- Regulates blood sugar, body temperature, bone health, appetite, gut motility, sexual health, wound healing, and immunity.
- Discovery of Serotonin-DNA Interaction
- In 2019, scientists found serotonin can enter cells and directly interact with DNA, switching on genes.
- Serotonin and Cancer Genes
- Studies show serotonin can switch on genes involved in cancer growth in brain, liver, and pancreatic cancers.
- Potential Therapies
- Targeted epigenetic therapies and managing serotonin levels through diet, gut microbiome, or SSRIs.
- SSRI Mechanism
- SSRIs block serotonin transport channels, limiting its entry into cells and thus its potential cancer-promoting effects.